The 12 Million People Lost in a Maze of Medicare and Medicaid
Many of America’s poorest and sickest patients are stuck navigating two separate insurance programs — Medicare and Medicaid — to get the care they need.
Read MoreMedicare
What to Expect When Medicare and Pharma Finally Negotiate Drug Prices
We explain how Medicare’s historic price negotiations with drugmakers will work, and the impact they could have.
Read More
Can Medicare Afford to Foot the Bill for New Alzheimer’s Drugs?
Recent analyses in JAMA and by the Kaiser Family Foundation raise questions about whether Medicare and its beneficiaries can afford a new wave of Alzheimer’s treatments.
Read More
One Economist’s Plan to Blow Up America’s Health Insurance System
Amy Finkelstein outlines an evidence-based plan to overhaul our patchwork of health insurance policies.
Read More
The Meteoric Rise of Private Medicare Advantage Insurance
What’s gained and what’s lost as private insurers manage an increasingly large share of the Medicare program?
Read More
The Wonky Policy That’s Got Hospitals on High Alert
Medicare could soon pay hospitals much less for common outpatient services like x-rays and checkups.
Read More
Medicare Director Meena Seshamani on CMS’ New Drug Pricing Powers
Medicare director Meena Seshamani discusses her team’s sprint to put historic drug price reforms into action.
Read More